The U.S. Chamber of Commerce filed a motion Wednesday for a preliminary injunction to block the implementation of the Medicare Drug Price Negotiation program.
Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk's Wegovy were still taking it a year later, while total healthcare costs for the group rose sharply.
U.S. regulators are allowing imports of additional supplies of a cancer drug from China amid a nationwide shortage that has forced doctors to ration care, putting patients' lives at risk.